Sector valuations Perspective Therapeutics, Inc.

Stocks

CATX

US46489V3024

Biotechnology & Medical Research

Market Closed - NYSE 04:00:00 2026-09-18 pm EDT			5-day change	1st Jan Change
2.880 ^USD	0.00%		+2.49%	+4.73%

Sep. 18	William Blair Initiates Perspective Therapeutics With Outperform Rating	MT
Sep. 14	Perspective Therapeutics, Inc. and Merck Announce Clinical Collaboration and Supply Agreement to Evaluate [212Pb]PSV359 in Combination with Keytruda (Pembrolizumab) in FAP-a Positive Solid Tumors	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	Price to Book (Y)	PEG (Y)	EV / Sales (Y)	EV / EBITDA (Y)	EV / EBIT (Y)	Dividend Yield (Y)	Capi.($)
PERSPECTIVE THERAPEUTICS, INC.	-2.89x	1.39x	0.1x	545.76x	-1.3x	-1.31x	-.--%	329M
LONZA GROUP AG	31.88x	4.26x	1.2x	5.74x	17.19x	24.05x	1.02%	46.28B
IQVIA HOLDINGS INC.	34.31x	6.27x	-35.85x	3.31x	14.29x	21.6x	-.--%	43.85B
REVOLUTION MEDICINES, INC.	-19.53x	20.19x	-0.3x	224.63x	-20.86x	-19.68x	-.--%	40.93B
BEONE MEDICINES AG	45.96x	7.78x	0.23x	5.31x	29.04x	33.42x	-.--%	39.89B
CELLTRION, INC.	27.09x	2.2x	0.55x	7.81x	19.95x	23.5x	0.42%	29.5B
MEDPACE HOLDINGS, INC.	34.82x	24.98x	2.31x	5.71x	25.95x	27.15x	-.--%	17.09B
EUROFINS SCIENTIFIC SE	25.48x	2.83x	0.74x	2.19x	9.51x	14.74x	1.05%	15.22B
TEMPUS AI, INC.	-55.89x	28.01x	45.42x	9.19x	224.28x	-2034.7x	-.--%	14.05B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	74.38x	4.41x	-0.33x	3.93x	15.26x	18.74x	-.--%	13.27B
ICON PUBLIC LIMITED COMPANY	27.86x	1.32x	0.27x	1.84x	11.31x	12.89x	-.--%	12.66B
BIO-TECHNE CORPORATION	52.38x	4.57x	2.74x	8.69x	24.67x	29.43x	0.44%	11.35B
PHARMARON BEIJING CO., LTD.	39.36x	4.58x	2.3x	4.68x	19.99x	31.74x	0.56%	10.89B
KYMERA THERAPEUTICS, INC.	-30.41x	8.84x	-6.16x	80.62x	-20.33x	-19.71x	-.--%	9.79B
PROTAGONIST THERAPEUTICS, INC.	30.75x	-	-0.09x	16.07x	29.33x	28.65x	-.--%	9.25B
ABIVAX	-25.66x	7.55x	0.97x	97.38x	-25.62x	-42.38x	-.--%	9.1B
QIAGEN N.V.	22.49x	2.38x	-32.06x	4.5x	12.1x	15.42x	0.31%	8.96B
PRAXIS PRECISION MEDICINES, INC.	-21.52x	7.43x	-7.05x	8892.1x	-17.56x	-17.3x	-.--%	8.35B
IMMUNOVANT, INC.	-12.52x	15.45x	-1.9x	-	-11.39x	-11.41x	-.--%	7.63B
Average	14.65x	8.58x	-1.42x	551.08x	18.73x	-98.17x	0.2%	18.34B
Weighted average by Cap.	20.24x	9.05x	-3.37x	254.71x	18.98x	-68.67x	0.26%

Other Biotechnology & Medical Research

-40%: Exceptional extension

SEIZE THE OFFER!